Keywords: Forest Labs, Financial results, Quarter ended June 30, 2012, Lexapro

Forest Lab's earnings plunge 79%, hit by generic Lexapro

Article | 18 July 2012

Print This

US drugmaker Forest Laboratories (Nasdaq: FRX) yesterday reported that net income for the quarter ended June 30, 2012, was down 79% as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in